Sign Up Today and Learn More About Lyndra Therapeutics Stock
Invest in or calculate the value of your shares in Lyndra Therapeutics or other pre-IPO companies through EquityZen's platform.
Lyndra Therapeutics Stock (LYDT)
Lyndra Therepeutics creates therapies for long-term drug release in an oral dose form.
About Lyndra Therapeutics Stock
Founded
2015
Headquarters
Watertown, MA, US
Industries
Science and Engineering, Health Care, Biotechnology
Lyndra Therapeutics Press Mentions
Stay in the know about the latest news on Lyndra Therapeutics
Sun Pharma to acquire 16.7% stake in Lyndra Therapeutics for $30 million
businesstoday • Jun 04, 2024
Sun Pharma to buy 16% stake of Lyndra Therapeutics for â‚ą249 crore
thehindubusinessline • Jun 04, 2024
Lyndra Therapeutics Raises $101 Million in Series E Funding
businesswire • Jun 04, 2024
Lyndra extends shelf life of its Lynx oral drug delivery platform
bioworld • May 23, 2024
Gilead-backed Lyndra Therapeutics cuts nearly a quarter of staff as ph. 3 data nears
fiercepharma • Sep 16, 2023
Lyndra Therapeutics Management
Leadership team at Lyndra Therapeutics
Executive Chairman & Co-Founder
Amy Schulman
Co-Founder
Colin R. Gardner
Join now and verify your accreditation status to gain access to:
- Lyndra Therapeutics current valuation
- Lyndra Therapeutics stock price
- Available deals in Lyndra Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Lyndra Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Lyndra Therapeutics through EquityZen funds. These investments are made available by existing Lyndra Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Lyndra Therapeutics stock?
Shareholders can sell their Lyndra Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
